Paliperidon-Mepha i.m. 25 mg

Paliperidon-Mepha i.m. 25 mg is a medicine authorised by Swissmedic under authorisation number 67852. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 October 2020 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 67852
  • Synthetic medicines
Authorisation data
Authorisation number67852
NamePaliperidon-Mepha i.m. 25 mg
Full namePaliperidon-Mepha i.m. 25 mg, Depot-Injektionssuspension in einer Fertigspritze
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation16 October 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Paliperidon-Mepha i.m. 25 mg, Depot-Injektionssuspension in einer FertigspritzeB16 October 2020
2Paliperidon-Mepha i.m. 50 mg, Depot-Injektionssuspension in einer FertigspritzeB16 October 2020
3Paliperidon-Mepha i.m. 75 mg, Depot-Injektionssuspension in einer FertigspritzeB16 October 2020
4Paliperidon-Mepha i.m. 100 mg, Depot-Injektionssuspension in einer FertigspritzeB16 October 2020
5Paliperidon-Mepha i.m. 150 mg, Depot-Injektionssuspension in einer FertigspritzeB16 October 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Paliperidon-Mepha i.m. 25 mg authorised in Switzerland?

Yes. Paliperidon-Mepha i.m. 25 mg is authorised by Swissmedic under authorisation number 67852, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Paliperidon-Mepha i.m. 25 mg have?

Paliperidon-Mepha i.m. 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Paliperidon-Mepha i.m. 25 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com